Real-world cost-effectiveness analysis of thymoglobulin versus no induction therapy in kidney transplant recipients at low risk of graft loss

Real-world cost-effectiveness analysis of thymoglobulin versus no induction therapy in kidney transplant recipients at low risk of graft loss

Abstract Background: A new induction therapy strategy of a single 3 mg/kg dose of rabbit antithymocyte globulin (r-ATG) showed a lower incidence of acute rejection. Methods: The objective of this study was to use real-world data to determine the incremental cost-effectiveness ratio (ICER) of r-ATG...

Full description

Saved in:
Bibliographic Details
Main Authors: Adrieli Barros Bessa, Marina Pontello Cristelli, Claudia Rosso Felipe, Renato Demarchi Foresto, Marcelo Cunio Machado Fonseca, Jose Medina Pestana, Helio Tedesco-Silva
Format: Article
Language:English
Published: Sociedade Brasileira de Nefrologia 2024-12-01
Series:Brazilian Journal of Nephrology
Subjects:
Cost-effectiveness
Real-world
Rabbit Antithymocyte Globulin
Kidney Transplantation
Online Access:http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0101-28002025000100304&lng=en&tlng=en
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items

Similar Items